Oncology

TG-Interacting Factor 1 expression quantitatively impacts survival in acute myeloid leukemia
Ling Yan, Julie A. Means-Powell, Danko Martincic, Vladimir D. Kravtsov, Yu Shyr, John P. Greer, Utpal P. Davé, Mark J. Koury, David Wotton, Rizwan Hamid, Stephen J. Brandt

medRxiv 2020.02.04.20020537; doi: https://doi.org/10.1101/2020.02.04.20020537

Add to Selected Citations
Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival
Mark Jesus M. Magbanua, Lamorna Brown-Swigart, Hsin-Ta Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Antony Tin, Raheleh Salari, Svetlana Shchegrova, Hemant Pawar, Amy L. Delson, Angela DeMichele, Minetta C. Liu, A. Jo Chien, Smita Asare, Cheng-Ho J. Lin, Paul Billings, Alexey Aleshin, Himanshu Sethi, Maggie Louie, Bernhard Zimmermann, Laura J. Esserman, Laura J. van ’t Veer

medRxiv 2020.02.03.20019760; doi: https://doi.org/10.1101/2020.02.03.20019760

Add to Selected Citations
Response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT pathway dysregulation and high tumour mutational burden
Joanne D Stockton, Louise Tee, Celina Whalley, Jonathan James, Mark Dilworth, Rachel Wheat, Thomas Nieto, Ian Geh, Andrew D Beggs

medRxiv 2020.02.01.20019794; doi: https://doi.org/10.1101/2020.02.01.20019794

Add to Selected Citations
Incidence and Risk Factors of Second Primary Cancer after the Initial Primary Human Papillomavirus Related Neoplasms
Jiayi Shen, Huaqiang Zhou, Jiaqing Liu, Zhonghan Zhang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Yuxiang Ma, Ting Zhou, Yaxiong Zhang, Hongyun Zhao, Yan Huang, Li Zhang

medRxiv 2020.01.29.19004507; doi: https://doi.org/10.1101/2020.01.29.19004507

Add to Selected Citations
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
Sasagu Kurozumi, Mansour Alsaleem, Cíntia J. Monteiro, Kartikeya Bhardwaj, Stacey E. P. Joosten, Takaaki Fujii, Ken Shirabe, Andrew R. Green, Ian O. Ellis, Emad A. Rakha, Nigel P. Mongan, David M. Heery, Wilbert Zwart, Steffi Oesterreich, Simon J. Johnston

medRxiv 2020.01.24.20018622; doi: https://doi.org/10.1101/2020.01.24.20018622

Add to Selected Citations
STK11 and KEAP1 Mutations as Prognostic Biomarkers in an Observational Real-World Lung Adenocarcinoma Cohort
Simon Papillon-Cavanagh, Parul Doshi, Radu Dobrin, Joseph Szustakowski, Alice M. Walsh

medRxiv 2020.01.23.20017566; doi: https://doi.org/10.1101/2020.01.23.20017566

Add to Selected Citations
Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer
Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail Shoben, Meng Zhao, Ewa Mrozek, Rachel M. Layman, Erin Macrae, Wenrui Duan, Jun Zhang, Nathan Hall, Chadwick L. Wright, Katharina Schregel, Susan Gillespie, Michael Berger, Andrea Camp, Jeffrey J. Chalmers, Priya Balasubramanian, Brandon L. Miller, Peter Amaya, Eleni Andreopoulou, Joseph Sparano, Charles L. Shapiro, Miguel Angel Villalona-Calero, Susan Geyer, Alice Chen, Michael R. Grever, Michael V Knopp, Bhuvaneswari Ramaswamy

medRxiv 2020.01.20.20018218; doi: https://doi.org/10.1101/2020.01.20.20018218

Add to Selected Citations
Immunotherapy Implication of Signature-Guided Biomarker Discovery for Trastuzumab-Resistant HER2-Positive Breast Cancer
Andrea Sand, Aspen T. Duffin, Geoffrey T. Riddell, Mitchel Piacsek, Brittany Last, Chaoyang Sun, Richard A. Rovin, Judy A. Tjoe, Jun Yin

medRxiv 2020.01.17.20017947; doi: https://doi.org/10.1101/2020.01.17.20017947

Add to Selected Citations
Metastatic breast cancer patient perception of somatic tumor genomic testing
Elizabeth J. Adams, Sarah Asad, Raquel Reinbolt, Katharine A. Collier, Mahmoud Abdel-Rasoul, Susan Gillespie, James L. Chen, Mathew A. Cherian, Anne M. Noonan, Sagar Sardesai, Jeffrey VanDeusen, Robert Wesolowski, Nicole Williams, Charles L. Shapiro, Erin R. Macrae, Robert Pilarski, Amanda E. Toland, Leigha Senter, Bhuvaneswari Ramaswamy, Clara N. Lee, Maryam B. Lustberg, Daniel G. Stover

medRxiv 2020.01.20.19015404; doi: https://doi.org/10.1101/2020.01.20.19015404

Add to Selected Citations
Tumor Mutational Burden Predicts Survival In Patients With Low Grade Gliomas Expressing Mutated IDH1
Mahmoud S Alghamri, Rohit Thalla, Ruthvik Avvari, Ali Dabaja, Ayman Taher, Lili Zhao, Maria G Castro, Pedro R Lowenstein

medRxiv 2020.01.20.20016766; doi: https://doi.org/10.1101/2020.01.20.20016766

Add to Selected Citations

Oncology

Pages